Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujana Movva

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Problems in Cancer|May 31, 2013
Emerging therapies for sarcomaSujana Movva
Oncotargets and Therapy|September 28, 2016
Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survivalColin Thomas, Sujana Movva
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Role of Molecular Profiling in Soft Tissue SarcomaTimothy Lindsay, Sujana Movva
Drugs|November 1, 2011
Systemic management strategies for metastatic soft tissue sarcomaSujana Movva, Claire Verschraegen
Current Problems in Cancer|May 31, 2013
Issues in the management of high-risk localized sarcomasKenneth Cardona, Sujana Movva
Expert Opinion on Biological Therapy|February 25, 2009
The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer managementSujana Movva, Claire Verschraegen
Current Treatment Options in Oncology|May 6, 2015
Role of genetic and molecular profiling in sarcomasScott M Norberg, Sujana Movva
The Surgical Clinics of North America|August 21, 2016
Systemic Therapy for Advanced Soft Tissue SarcomaJennifer Y Sheng, Sujana Movva
Current Problems in Cancer|May 31, 2013
Multimodality therapy for advanced or metastatic sarcomaKenneth Cardona, Roger Williams, Sujana Movva
JCO Precision Oncology|June 8, 2022
Interpreting Nonrandomized Clinical Trial Data in Low-Grade Sarcoma: Differentiating Clinical Benefit From Indolent Disease Is KeyEvan Rosenbaum, Sujana Movva, Ciara Kelly
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Problems in Cancer|May 31, 2013
Emerging therapies for sarcomaSujana Movva
Oncotargets and Therapy|September 28, 2016
Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survivalColin Thomas, Sujana Movva
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Role of Molecular Profiling in Soft Tissue SarcomaTimothy Lindsay, Sujana Movva
Drugs|November 1, 2011
Systemic management strategies for metastatic soft tissue sarcomaSujana Movva, Claire Verschraegen
Current Problems in Cancer|May 31, 2013
Issues in the management of high-risk localized sarcomasKenneth Cardona, Sujana Movva
Expert Opinion on Biological Therapy|February 25, 2009
The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer managementSujana Movva, Claire Verschraegen
Current Treatment Options in Oncology|May 6, 2015
Role of genetic and molecular profiling in sarcomasScott M Norberg, Sujana Movva
The Surgical Clinics of North America|August 21, 2016
Systemic Therapy for Advanced Soft Tissue SarcomaJennifer Y Sheng, Sujana Movva
Current Problems in Cancer|May 31, 2013
Multimodality therapy for advanced or metastatic sarcomaKenneth Cardona, Roger Williams, Sujana Movva
JCO Precision Oncology|June 8, 2022
Interpreting Nonrandomized Clinical Trial Data in Low-Grade Sarcoma: Differentiating Clinical Benefit From Indolent Disease Is KeyEvan Rosenbaum, Sujana Movva, Ciara Kelly
Pageof 6